News
ANA Therapeutics and Quotient Sciences Announce Partnership to Manufacture Niclosamide Drug Candidate as a Potential Treatment for COVID-19
Quotient and ANA Therapeutics announce partnership to develop drug candidate, ANA001 (niclosamide capsules) as a potential treatment for COVID-19.